NCT00113971View on ClinicalTrials.gov

Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)

PHASE2TerminatedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

March 31, 2007

Study Completion Date

June 30, 2007

Conditions

Lupus Erythematosus, Systemic

Interventions

DRUG

epratuzumab

Trial Locations (3)

10032

Columbia Presbyterian Medical Center, New York

15261

Lupus Center of Excellence, Pittsburgh

29407

Rheumatology Associates, Charleston

Sponsors

Lead Sponsor

All Listed Sponsors

lead

UCB Pharma

INDUSTRY